Genor Biopharma Holdings Limited (FRA:67N0)

Germany flag Germany · Delayed Price · Currency is EUR
0.378
+0.022 (6.18%)
At close: Nov 26, 2025
140.76%
Market Cap 217.29M
Revenue (ttm) 26.63M
Net Income (ttm) 3.44M
Shares Out n/a
EPS (ttm) 0.01
PE Ratio 63.22
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 153
Open 0.378
Previous Close 0.356
Day's Range 0.378 - 0.378
52-Week Range 0.152 - 0.570
Beta n/a
RSI 56.47
Earnings Date Nov 28, 2025

About Genor Biopharma Holdings

Genor Biopharma Holdings Limited, a biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally. The company’s principal drug candidates include GB242, an infliximab (Remicade) biosimilar for rheumatoid arthritis, ankylosing spondylitis, psoriasis, adult ulcerative colitis, and Crohn’s disease; GB491 (lerociclib), an oral CDK4/6 inhibitor for breast cancer; and GB492, a stimulator of interferon genes combined with GB226, currently under Phase 1/2 clinical trial to treat solid t... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2007
Employees 24
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 67N0
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.